Although the Trump administration has pumped money into helping AstraZeneca develop a COVID-19 vaccine, the administration will only pay for the 300 million doses the company plans to deliver if the vaccine works well enough for FDA to grant it an emergency use authorization, an HHS spokesperson said. That means HHS discussed a price for the vaccine in advance, which some have been saying for months should happen . HHS and AstraZeneca issued press releases that say HHS will pay...